Delivery Order SPE2DB24D2010-SPE2DB25FAAXM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $1,211.69. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger federal contract portfolio...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes valued at $4,650.21 with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The contract represents a...
- The Defense Logistics Agency awarded a $3,153.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of August 14, 2025, and performance to be executed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The product is a hyaluronic acid injection used for osteoarthritis management,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,192.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 mL syringes (2 mL quantity) on September 18, 2025, with completion scheduled for September 19, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,287.75 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,090.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 7, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,424.26. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizing firm fixed price pricing. This is a non-set-aside competitive award, and the place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,454.88 under a firm fixed-price contract. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded without set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $5,342.85 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes on September 11, 2025, with completion scheduled for September 12, 2025. EUFLEXXA is a hyaluronic acid-based injectable treatment commonly used for knee osteoarthritis pain management. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAXMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,690.32 to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. Euflexxa is a hyaluronic acid-based injectable treatment commonly used for osteoarthritis management, reflecting the broad range of pharmaceutical and medical supplies that AmerisourceBergen delivers through its DLA contract vehicle. The SPE2DX IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialty healthcare commodities across multiple therapeutic domains to support military healthcare programs. This delivery order exemplifies the company's role as a critical federal vendor for Department of Defense medical procurement, with the flexibility to fulfill diverse and time-sensitive pharmaceutical requirements across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 8/21/25 |